UPPTHERA
PrivateLast Round
Series B
Extension
Jul 24, 2023
Total Funding Raised
$41.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
UPPTHERA is a pharmaceutical company that develops innovative drugs based on targeted protein degradation technology to address unmet medical needs in oncology and other disease areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UPPTHERA Comparables
Compare UPPTHERA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 88% | |
| Ubix Therapeutics | 88% | |
| Plexium | 86% |
UPPTHERA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 24, 2023 | ||||
| Series B | May 18, 2022 | ||||
| Series A | Jul 14, 2020 | ||||
| Pre Seed | Mar 1, 2019 |
Key People
Founding team and executive leadership
UPPTHERA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series B, Series A |
| Paratus Investment | Series B |
| Meritz Securities Co., Ltd. | Series B |
| SBI Investment Korea | Series B |
| Enlight Ventures | Series B, Series A |
| IMM Investment | Series B, Series A |
| SBI Investment Co., Ltd. | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 74% MoM.
- May 1, 2025
Monthly visitors increased 1253% MoM, reaching 2.3K.
UPPTHERA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about UPPTHERA's valuation, stock price, and market status.
Is UPPTHERA a public or private company?
UPPTHERA is a private company.
What is the current stock price of UPPTHERA?
UPPTHERA is a private company with no public stock price. No recent secondary market data is available.
How much is UPPTHERA worth (valuation)?
Valuation information for UPPTHERA is not publicly available.
Can I buy UPPTHERA stock?
UPPTHERA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was UPPTHERA's last funding round?
UPPTHERA's most recent funding round was Series B Extension on July 24, 2023.
Who are the main investors in UPPTHERA?
Key investors in UPPTHERA include KDB Capital Corp, Paratus Investment, Meritz Securities Co., Ltd., SBI Investment Korea, Enlight Ventures.
Will UPPTHERA IPO soon?
No public IPO plans have been announced for UPPTHERA.
How can I track UPPTHERA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UPPTHERA's secondary market activity and sign up for updates.